|
Extramural Support
|
RMS2013 [E]
|
$366,054,072
|
$82,435
|
N/A
|
National Cancer Institute
|
|
Role of ASXL1 mutations in myeloid malignancies
|
5K08CA160647-03
|
$169,884
|
$169,884
|
Abdel-Wahab, Omar
|
SLOAN-KETTERING INST CAN RES
|
|
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and Function
|
5R01CA140622-03
|
$355,357
|
$355,357
|
ABRAMS, SCOTT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S1
|
$75,000
|
$2,250
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Rational Design and Clinical Development of Shepherdin: A Novel Anti-Cancer Agent
|
5R01CA118005-06
|
$325,422
|
$55,322
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Exploiting altered glucose utilization in Bcr-Abl+ Leukemia
|
5F31CA157166-04
|
$42,232
|
$42,232
|
Alvarez-Calderon, Francesca
|
UNIVERSITY OF COLORADO DENVER
|
|
Adult Leukemia Research Center
|
5P01CA018029-38
|
$3,971,921
|
$158,877
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CAN RES CTR
|
|
The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission)
|
5R01CA160433-02
|
$315,981
|
$315,981
|
ARMANIOS, MARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Improved therapeutic approaches for hematological disorder treated with tyrosine
|
5R01CA155091-02
|
$298,427
|
$298,427
|
Azam, Mohammad
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
A novel hematopoietic stem cell population
|
1F31CA180604-01
|
$45,637
|
$22,819
|
Balcerek, Joanna
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer and Leukemia Group B Human Specimen Repositories
|
5U24CA114725-09
|
$1,086,261
|
$543,131
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
MOLECULAR STUDIES OF BONE MARROW FAILURE
|
5R01CA105312-08
|
$544,060
|
$544,060
|
BESSLER, MONICA
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Microenvironmental Regulation of Leukemia Stem Cells
|
1R01CA172447-01A1
|
$348,600
|
$348,600
|
BHATIA, RAVI
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Resistance of CML Stem Cells to Imatinib (Gleevec)
|
2R01CA095684-10
|
$314,718
|
$314,718
|
BHATIA, RAVI
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
5K23CA154532-03
|
$170,100
|
$85,050
|
Bleakley, Marie
|
FRED HUTCHINSON CAN RES CTR
|
|
Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia
|
1R01CA165469-01A1
|
$393,015
|
$393,015
|
BONDADA, SUBBARAO
|
UNIVERSITY OF KENTUCKY
|
|
Mechanisms linking RAS signals to disordered hematopoiesis and myeloid neoplasia
|
1R01CA173085-01A1
|
$325,948
|
$325,948
|
BRAUN, BENJAMIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
1st Annual Tandem ASPHO/PBMTC Educational Mtg: New Frontiers in Pediatric AlloSCT
|
1R13CA177155-01
|
$5,000
|
$5,000
|
Cairo, Mitchell
|
NEW YORK MEDICAL COLLEGE
|
|
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
|
1R01CA167169-01A1
|
$321,625
|
$321,625
|
CALABRETTA, BRUNO
|
THOMAS JEFFERSON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-37S1
|
$121,802
|
$3,654
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-37S2
|
$12,500
|
$375
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA016058-37
|
$4,284,455
|
$128,534
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Therapeutic Targeting of Leukemia-Microenvironmental Interactions
|
1R01CA166280-01A1
|
$318,513
|
$318,513
|
CALVI, LAURA
|
UNIVERSITY OF ROCHESTER
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-14S1
|
$113,245
|
$3,397
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-14S2
|
$71,639
|
$2,149
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
5P30CA071789-14
|
$1,063,659
|
$31,910
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
The Therapy of CML
|
5P01CA049639-23
|
$3,383,296
|
$3,383,296
|
CHAMPLIN, RICHARD
|
UT MD ANDERSON CANCER CTR
|
|
Role of Shp2 in FLT3-ITD-Induced Leukemogenesis
|
5R01CA134777-03
|
$300,377
|
$300,377
|
CHAN, REBECCA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Roles of SIRT1 in normal hematopoietic and leukemic stem cells
|
5R01CA143421-03
|
$294,916
|
$294,916
|
CHEN, WENYONG
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Fanconi anemia pathway in DNA damage repair
|
5R01CA157448-02
|
$308,179
|
$308,179
|
CHEN, JUNJIE
|
UT MD ANDERSON CANCER CTR
|
|
Novel SET Antagonists for the Treatment of Chronic Myelogenous Leukemia
|
3R41CA165570-01S1
|
$149,800
|
$149,800
|
Christensen, Dale
|
ONCOTIDE PHARMACEUTICALS, INC.
|
|
Mechanism of novel transmembrane proteins that induce erythroid differentiation
|
1F31CA168012-01A1
|
$26,802
|
$26,802
|
Cohen, Emily
|
YALE UNIVERSITY
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S1
|
$109,383
|
$2,188
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S2
|
$18,750
|
$375
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S3
|
$125,000
|
$2,500
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S4
|
$50,000
|
$1,000
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
Cancer Center Support Grant (Comprehensive)
|
5P30CA015704-39
|
$10,072,717
|
$201,454
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-35
|
$3,676,771
|
$110,303
|
CRESS, ANNE
|
UNIVERSITY OF ARIZONA
|
|
Mechanisms of Leukemogenesis in Down Syndrome
|
5R01CA101774-11
|
$285,728
|
$285,728
|
CRISPINO, JOHN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
TOWARD AN UNDERSTANDING OF CLL PROGRESSION
|
5R01CA151319-03
|
$352,327
|
$352,327
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
Validating a novel biomarker of clinical progression and survival in CLL
|
5R33CA161731-03
|
$364,740
|
$364,740
|
DAVIS, RANDALL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Cancer Center Support (CORE) Grant
|
2P30CA016672-38
|
$9,725,847
|
$680,809
|
DEPINHO, RONALD
|
UT MD ANDERSON CANCER CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-38S1
|
$74,957
|
$5,247
|
DEPINHO, RONALD
|
UT MD ANDERSON CANCER CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-38S2
|
$50,000
|
$3,500
|
DEPINHO, RONALD
|
UT MD ANDERSON CANCER CTR
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-16S1
|
$75,000
|
$3,000
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-16S2
|
$116,354
|
$4,654
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
5P30CA069533-16
|
$1,061,540
|
$42,462
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Chronic Myelogenous Leukemia and BCR-ABL Substrates
|
5R37CA065823-18
|
$291,676
|
$291,676
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Role of Setbp1 in leukemic stem cell self-renewal
|
5R01CA143193-04
|
$289,474
|
$289,474
|
Du, Yang
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
|
Single Molecule Fiber Arrays for the Detection of Low Abundance Proteins
|
6R44CA133987-05
|
$713,497
|
$142,699
|
Duffy, David
|
QUANTERIX CORPORATION
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $37,051,523
|